202 related articles for article (PubMed ID: 29882087)
1. The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment.
Borghans LGJM; Sambeth A; Prickaerts J; Ramaekers JG; Blokland A
Psychopharmacology (Berl); 2018 Aug; 235(8):2407-2416. PubMed ID: 29882087
[TBL] [Abstract][Full Text] [Related]
2. Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms.
Nelissen E; van Hagen BTJ; Argyrousi EK; van Goethem NP; Heckman PRA; Paes D; Mulder-Jongen DAJ; Ramaekers JG; Blokland A; Schmidt HHHW; Prickaerts J
Neurosci Lett; 2022 Sep; 788():136840. PubMed ID: 35985509
[TBL] [Abstract][Full Text] [Related]
3. Biperiden Selectively Impairs Verbal Episodic Memory in a Dose- and Time-Dependent Manner in Healthy Subjects.
Borghans L; Sambeth A; Blokland A
J Clin Psychopharmacol; 2020; 40(1):30-37. PubMed ID: 31834098
[TBL] [Abstract][Full Text] [Related]
4. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
5. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
[TBL] [Abstract][Full Text] [Related]
6. The chemistry and biology of soluble guanylate cyclase stimulators and activators.
Follmann M; Griebenow N; Hahn MG; Hartung I; Mais FJ; Mittendorf J; Schäfer M; Schirok H; Stasch JP; Stoll F; Straub A
Angew Chem Int Ed Engl; 2013 Sep; 52(36):9442-62. PubMed ID: 23963798
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation.
Benke K; Németh BT; Sayour AA; Stark KA; Oláh A; Ruppert M; Szabó G; Korkmaz-Icöz S; Horváth EM; Benkő R; Hartyánszky I; Szabolcs Z; Merkely B; Radovits T
Sci Rep; 2020 Mar; 10(1):5358. PubMed ID: 32210293
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylate cyclase stimulators in pulmonary hypertension.
Stasch JP; Evgenov OV
Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
Næsheim T; How OJ; Myrmel T
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):75-87. PubMed ID: 32662299
[TBL] [Abstract][Full Text] [Related]
11. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Lian TY; Jiang X; Jing ZC
Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514
[TBL] [Abstract][Full Text] [Related]
12. Effects of biperiden and acute tryptophan depletion and their combination on verbal word memory and EEG.
Borghans LG; Blokland A; Sambeth A
Psychopharmacology (Berl); 2017 Apr; 234(7):1135-1143. PubMed ID: 28210777
[TBL] [Abstract][Full Text] [Related]
13. Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram.
Sambeth A; Riedel WJ; Klinkenberg I; Kähkönen S; Blokland A
Psychopharmacology (Berl); 2015 Jun; 232(11):1887-97. PubMed ID: 25466702
[TBL] [Abstract][Full Text] [Related]
14. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.
Wezenberg E; Verkes RJ; Sabbe BG; Ruigt GS; Hulstijn W
Psychopharmacology (Berl); 2005 Sep; 181(3):582-94. PubMed ID: 16041534
[TBL] [Abstract][Full Text] [Related]
15. The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.
Reiss C; Mindukshev I; Bischoff V; Subramanian H; Kehrer L; Friebe A; Stasch JP; Gambaryan S; Walter U
Br J Pharmacol; 2015 Nov; 172(21):5199-210. PubMed ID: 26282717
[TBL] [Abstract][Full Text] [Related]
16. A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers.
Azadi S; Ashrafi H; Azadi A
Curr Drug Discov Technol; 2018; 15(1):20-23. PubMed ID: 28914189
[TBL] [Abstract][Full Text] [Related]
17. Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors.
Hoeper MM; Klinger JR; Benza RL; Simonneau G; Langleben D; Naeije R; Corris PA
Respir Med; 2017 Jan; 122 Suppl 1():S18-S22. PubMed ID: 27887774
[TBL] [Abstract][Full Text] [Related]
18. Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.
Bakker C; van Esdonk MJ; Stuurman RFE; Borghans LGJM; de Kam ML; van Gerven JMA; Groeneveld GJ
J Clin Pharmacol; 2021 Nov; 61(11):1466-1478. PubMed ID: 34021607
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats.
Geschka S; Kretschmer A; Sharkovska Y; Evgenov OV; Lawrenz B; Hucke A; Hocher B; Stasch JP
PLoS One; 2011; 6(7):e21853. PubMed ID: 21789188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
